Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
7.03
+0.10 (1.44%)
Apr 24, 2025, 4:10 PM AEST

Mayne Pharma Group Market Cap

Mayne Pharma Group has a market cap or net worth of 571.16 million as of April 24, 2025. Its market cap has decreased by -0.42% in one year.

Market Cap
571.16M
Enterprise Value
486.11M
Revenue
413.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.03

Market Cap Chart

Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 571.16M, an increase of 1,150.91%. That is a compound annual growth rate of 15.22%.

History

DateMarket Cap% Change
Apr 24, 2025571.16M41.45%
Dec 31, 2024403.79M-19.19%
Dec 29, 2023499.66M43.60%
Dec 30, 2022347.96M-33.16%
Dec 31, 2021520.63M-10.12%
Dec 31, 2020579.28M-20.69%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 114.55B
Pro Medicus 21.45B
Cochlear 17.02B
Sonic Healthcare 12.02B
Telix Pharmaceuticals 8.51B
Ramsay Health Care 7.54B
Ansell 4.14B
Mesoblast 2.11B
Market Cap Rankings